相似文献
1
Screening for latent tuberculosis: the way forward for tuberculosis elimination.
Reumatologia. 2022;60(6):363-365. doi: 10.5114/reum.2022.123666. Epub 2022 Dec 30.
2
Estimating the long-term effects of mass screening for latent and active tuberculosis in the Marshall Islands.
Int J Epidemiol. 2022 Oct 13;51(5):1433-1445. doi: 10.1093/ije/dyac045.
3
Tuberculosis elimination in the post Millennium Development Goals era.
Int J Infect Dis. 2015 Mar;32:152-5. doi: 10.1016/j.ijid.2014.11.020.
4
Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.
Lancet Infect Dis. 2017 Oct;17(10):e327-e333. doi: 10.1016/S1473-3099(17)30248-7. Epub 2017 May 8.
5
Mandatory screening and treatment of immigrants for latent tuberculosis in the USA: just restraint?
Lancet Infect Dis. 2001 Nov;1(4):270-6. doi: 10.1016/s1473-3099(01)00122-0.
6
Screening for hepatitis B virus infection among refugees diagnosed with latent tuberculosis in an Italian community.
Ann Ig. 2021 Nov-Dec;33(6):602-614. doi: 10.7416/ai.2021.2452. Epub 2021 Jul 6.
7
New developments in the treatment of latent tuberculosis.
Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S176-81.
8
Diagnosis and Management of Latent Tuberculosis Infection.
Cold Spring Harb Perspect Med. 2015 Jun 8;5(11):a017830. doi: 10.1101/cshperspect.a017830.
9
Providing detailed information about latent tuberculosis and compliance with the PPD test among healthcare workers in Israel: a randomized controlled study.
J Epidemiol Glob Health. 2013 Dec;3(4):253-60. doi: 10.1016/j.jegh.2013.06.003. Epub 2013 Jul 10.
10
Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
Euro Surveill. 2022 Mar;27(12). doi: 10.2807/1560-7917.ES.2022.27.12.2002070.
本文引用的文献
1
Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5 years of age.
Sci Rep. 2022 Nov 19;12(1):19908. doi: 10.1038/s41598-022-24433-w.
2
Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Eur J Pediatr. 2023 Jan;182(1):307-317. doi: 10.1007/s00431-022-04640-3. Epub 2022 Nov 5.
3
Positive rates of interferon-γ release assay and tuberculin skin test in detection of latent tuberculosis infection: A systematic review and meta-analysis of 200,000 head-to-head comparative tests.
Clin Immunol. 2022 Dec;245:109132. doi: 10.1016/j.clim.2022.109132. Epub 2022 Sep 30.
4
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
Lancet Infect Dis. 2021 Dec;21(12):1701-1712. doi: 10.1016/S1473-3099(21)00052-9. Epub 2021 Aug 4.
5
Self-clearance of infection: implications for lifetime risk and population at-risk of tuberculosis disease.
Proc Biol Sci. 2021 Jan 27;288(1943):20201635. doi: 10.1098/rspb.2020.1635. Epub 2021 Jan 20.
6
Screening migrants from tuberculosis high-endemic countries for latent tuberculosis in Oman: A cross sectional cohort analysis.
Travel Med Infect Dis. 2020 Sep-Oct;37:101734. doi: 10.1016/j.tmaid.2020.101734. Epub 2020 May 11.
7
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808.
8
Stratification by interferon-γ release assay level predicts risk of incident TB.
Thorax. 2018 Apr 5. doi: 10.1136/thoraxjnl-2017-211147.
9
National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area.
Eur Respir J. 2018 Jan 11;51(1). doi: 10.1183/13993003.01226-2017. Print 2018 Jan.
10
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.
Lancet Respir Med. 2017 Apr;5(4):282-290. doi: 10.1016/S2213-2600(17)30060-7. Epub 2017 Feb 16.
Zotero 插件